Pages that link to "Q87132965"

The following pages link to Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing (Q87132965):

Displaying 40 items.

• Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications (Q26775927) (← links)
• Gut microbiota: its role in hepatic encephalopathy (Q28084576) (← links)
• Gut Microbiota and Complications of Liver Disease (Q30236024) (← links)
• Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). (Q33748498) (← links)
• Co-occurrence of driver and passenger bacteria in human colorectal cancer (Q33842013) (← links)
• The role of microbiota in hepatic encephalopathy (Q34129402) (← links)
• Duodenal ferroportin is up-regulated in patients with chronic hepatitis C (Q34374269) (← links)
• Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota (Q34590195) (← links)
• Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis (Q34647371) (← links)
• The gut microbiome and the brain (Q34652493) (← links)
• Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study (Q35003443) (← links)
• Altered profile of human gut microbiome is associated with cirrhosis and its complications (Q35077209) (← links)
• Altered fecal microbiota composition associated with food allergy in infants. (Q35095111) (← links)
• Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis (Q35790974) (← links)
• Longitudinal analysis reveals characteristically high proportions of bacterial vaginosis-associated bacteria and temporal variability of vaginal microbiota in northern pig-tailed macaques (Macaca leonina). (Q35802094) (← links)
• Probiotics in management of hepatic encephalopathy (Q38819352) (← links)
• Gut microbiome and liver disease (Q38914215) (← links)
• Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice (Q39658427) (← links)
• Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis (Q39735819) (← links)
• What is new about diet in hepatic encephalopathy (Q40486028) (← links)
• Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications (Q41036794) (← links)
• Decompensated cirrhosis and microbiome interpretation (Q43204427) (← links)
• The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma (Q44987249) (← links)
• Meta-analysis of gut microbiome studies identifies disease-specific and shared responses (Q46247318) (← links)
• Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. (Q46253420) (← links)
• Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients (Q47117570) (← links)
• The Pharmabiotic Approach to Treat Hyperammonemia. (Q47831420) (← links)
• Hepatic encephalopathy: current challenges and future prospects. (Q54243938) (← links)
• Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. (Q55516336) (← links)
• Microbiome and complications of liver disease. (Q64986683) (← links)
• Neuroinflammation in Murine Cirrhosis is Dependent on the Gut Microbiome and is Attenuated by Fecal Transplant. (Q64997071) (← links)
• [Relationship between oral and gut microbes] (Q88443775) (← links)
• Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs (Q90134544) (← links)
• Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation (Q90205918) (← links)
• Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial (Q91639788) (← links)
• Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis (Q91783628) (← links)
• Gut Microbiota as Biosensors in Patients With Cirrhosis (Q92316425) (← links)
• Fecal microbiota transplantation beyond Clostridioides difficile infections (Q92759829) (← links)
• Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? (Q92999660) (← links)
• Gut Microbiota Dysbiosis Associated with Bile Acid Metabolism in Neonatal Cholestasis Disease (Q94592350) (← links)